GPhA Supports DEA National Prescription Drug Take-Back Day
Contact: Steve Arnoff 202.249.7113
WASHINGTON, DC (April 29, 2015) — The Generic Pharmaceutical Association (GPhA) applauds the U.S. Drug Enforcement Agency’s (DEA) National Prescription Drug Take-Back Day, taking place Saturday, April 30th at locally designated collection sites across the country.
According to the DEA website, “National Prescription Drug Take-Back Day aims to provide a safe, convenient, and responsible means of disposing of prescription drugs, while also educating the general public about the potential for abuse of medications.”
“The smartest way to avoid any safety or health issues is to use all medicines as directed by a healthcare professional,” said Chip Davis, President and CEO, GPhA. “Prescription adherence and proper disposal, in-home or through take-back days, helps to stop drug abuse by limiting opportunities for misuse or diversion, an effort that is especially important for older patients and families.”
More details, including a list of local collection sites, are available at: www.deadiversion.usdoj.gov/drug_disposal/takeback/
GPhA represents the manufacturers and distributors of finished generic pharmaceuticals, manufacturers and distributors of bulk pharmaceutical chemicals, and suppliers of other goods and services to the generic industry. Generic pharmaceuticals fill 88 percent of the prescriptions dispensed in the U.S. but consume just 28 percent of the total drug spending. Additional information is available at gphaonline.org. Follow us on twitter: @gpha.